A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants
Condition: Healthy Volunteers Interventions: Drug: Brensocatib; Drug: Rifampin; Drug: Esomeprazole Sponsor: Insmed Incorporated Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
